Emergent BioSolutions Inc. (LON:0IGA)
London · Delayed Price · Currency is GBP · Price in USD 5.67
-0.30 (-5.03%)
At close: Aug 1, 2025
Emergent BioSolutions Market Cap
Emergent BioSolutions has a market cap or net worth of 230.70 million as of August 1, 2025. Its market cap has decreased by -52.36% in one year.
Market Cap
230.70M
Enterprise Value
625.98M
Revenue
747.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.67
Market Cap Chart
Since November 15, 2006, Emergent BioSolutions's market cap has increased from 169.95M to 230.70M, an increase of 35.74%. That is a compound annual growth rate of 1.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 230.70M | -44.24% |
| Dec 31, 2024 | 413.76M | 323.24% |
| Dec 29, 2023 | 97.76M | -80.01% |
| Dec 30, 2022 | 488.99M | -71.69% |
| Dec 31, 2021 | 1.73B | -50.34% |
| Dec 31, 2020 | 3.48B | 65.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 175.60B |
| GSK plc | 57.26B |
| Haleon | 32.31B |
| Smith & Nephew | 10.17B |
| ConvaTec Group | 4.77B |
| Hikma Pharmaceuticals | 4.33B |
| HUTCHMED (China) | 2.34B |
| Oxford Nanopore Technologies | 1.96B |